对以人为中心的生物医学产品设计设置中的应用进行了辅助性成分的检查
Lewis Urquhart1, Francesco Tamburrino2, Paolo Neri2
1University of Strathclyde, Glasgow, UK.
概括
研究人员检查了为以人为中心的生物医学设计增材制造的辅助成分. 一个新的测试设置分析了重新进入的,的和半刚性的辅助结构,为开发人体工程学医疗设备提供了洞察力.
科学领域:
- 材料科学 材料科学 材料科学
- 生物医学工程 生物医学工程
- 机械工程 机械工程
背景情况:
- 具有负波桑比率的辅助材料具有独特的机械性能.
- 增材制造使专业应用的复杂辅助几何体成为可能.
- 以人为中心的设计原则对于有效的生物医学产品开发至关重要.
研究的目的:
- 研究添加制造的辅助成分在以人为中心的生物医学设计中的应用.
- 为了应对测试辅助性材料的挑战,特别是边界条件.
- 在不同的参数下评估不同辅助性结构的性能.
主要方法:
- 辅助剂的详细设计应用和研究挑战的审查.
- 引入了一种具有独特零件安装的新型测试设置,用于光学分析和实时测量.
- 在具有不同参数的柔性TPU材料中添加制造三种辅助性结构 (回入性,性,半刚性).
主要成果:
- 测试设置有效地促进了对不同辅助性结构的检查.
- 内部几何和墙壁厚度的变化影响了auxetic样本的性能.
- 证明了设置在不同条件下分析辅助性行为的能力.
结论:
- 该研究提供了一种经过验证的方法来分析增材制造的辅助性结构.
- 研究结果为将辅助成分分析纳入生物医学器件设计工作流程提供了洞察力.
- 突出了辅助性材料在创建先进,以人为中心的医疗产品,以改善人体工程学和可用性的潜力.
相关概念视频
Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
Clinically Relevant Drug Product Specifications: Methods of Establishment
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...


